ArticleDiagnostics (Basel, Switzerland)2023
Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud's Phenomenon in the Lifelines Population: Focus on Pulmonary Complications.
Saskia Corine van de Zande, Amaal Eman Abdulle, Yehya Al-Adwi, Alja Stel, Karina de Leeuw, Elisabeth Brouwer, Suzanne Arends, Christiaan Tji Gan, Harry van Goor, Douwe Johannes Mulder
Open access · goldAbstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors at 1 institution in 1 country.
Saskia Corine van de ZandeDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.ORCID 0000-0002-3063-0260 Amaal Eman AbdulleDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.ORCID 0000-0003-3766-2238 Yehya Al-AdwiDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.ORCID 0000-0001-5406-7604 Alja StelDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.
Karina de LeeuwDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.
Elisabeth BrouwerDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.
Suzanne ArendsDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.ORCID 0000-0002-4422-7640 Christiaan Tji GanDepartment of Pulmonary Diseases and Tuberculosis, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.
Harry van GoorDepartment of Pathology and Medical Biology, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.ORCID 0000-0002-6670-1577 Douwe Johannes MulderDepartment of Internal Medicine, Division of Vascular Medicine, University Medical Centre Groningen, University of Groningen, 9712 Groningen, The Netherlands.ORCID 0000-0003-3715-6474 University Medical Center Groningen · NL
Funding
Thermo Fisher Scientific (Germany) 115142-2
6 · The paper itselfAbstract
Puffy fingers and Raynaud's phenomenon (RP) are important clinical predictors of the development of systemic sclerosis (SSc). We aim to assess the prevalence of SSc-related symptoms, explore pulmonary symptoms, and test the usefulness of skin autofluorescence (SAF) as a non-invasive marker for Advanced Glycation Endproducts (AGEs). Subjects from the Lifelines Cohort Study with known connective tissue disease (CTD) were excluded. Patient characteristics, SAF, self-reported pulmonary symptoms, and spirometry were obtained. Subjects (
Indexed as
epidemiologypulmonary involvementRaynaud’s phenomenonskin autofluorescencesystemic sclerosis
Identifiers
PMID37443554
PMCPMC10340274
OpenAlexW4382067205
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390